Universe Pharmaceuticals INC Cash and Restricted Cash
Universe Pharmaceuticals INC (UPC) had Cash and Restricted Cash of $33.59 billion as of 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-01-29
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.59B.
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29.50B; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $29.50M.
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.86M.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.29B; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $5.29M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-09-30 | $33.59B 20-F · filed 2026-01-29 | |
| 2024-09-30 | $29.50B 20-F · filed 2026-01-29 | $29.50M 20-F · filed 2025-04-29 |
| 2024-03-31 | $8.86M 6-K · filed 2024-09-20 | |
| 2023-09-30 | $5.29B 20-F · filed 2026-01-29 | $5.29M 20-F · filed 2024-01-30 |
| 2023-03-31 | $12.95M 6-K · filed 2024-09-20 | |
| 2022-09-30 | $5.71B 20-F · filed 2026-01-29 | $5.71M 20-F · filed 2023-02-10 |
| 2022-03-31 | $14.24M 6-K · filed 2023-08-31 | |
| 2021-09-30 | $8.08M 20-F · filed 2025-04-29 | |
| 2021-03-31 | $36.00M 6-K · filed 2022-08-16 | |
| 2020-09-30 | $10.06M 20-F · filed 2024-01-30 | |
| 2019-09-30 | $3.18M 20-F · filed 2023-02-10 |